摘要
2019年St.Gallen会议讨论了早期乳腺癌辅助治疗中的热点与争议问题。会议以危险度的划分为中心,探讨了如何确定高风险患者,并根据危险度决定进一步的治疗,并公布了SOUND研究的初步结果,为腋窝淋巴结的减法提供了更多的证据。作者结合单中心经验,对会议中外科治疗方面的热点问题如在手术范围缩小的适应证不断扩大的趋势下,外科手术在早期乳腺癌治疗中的不可替代的作用等进行了进一步的深度解读。
Hotspots and controversies on adjuvant therapy for early stage breast cancer were discussed in the st.Gallen International Breast Cancer Conference 2019.Focusing on the classification of risk,conferee discussed the identification of high risk patients and clinical decision based on the degree of risk.In terms of surgical treatment,under the trend of expanding indications for reduction of surgical scope and partial omission of surgery,the irreplaceable role of surgery in the treatment of early breast cancer was mainly discussed.The preliminary data of SOUND study were declared,which provided more evidences for deescalating in axillary surgery.This paper presentsan overview of the surgical issues in this conference.
作者
扈杰杰
俞洋
王晓稼
HU Jiejie;YU Yang;WANG Xiaojia(Department of Breast Surgery,Cancer Hospital of the University of Chinese Academy of Sciences,Hangzhou 310022,China)
出处
《中国肿瘤外科杂志》
CAS
2019年第6期397-400,共4页
Chinese Journal of Surgical Oncology